グラニセトロン市場：製品タイプ、用途、エンドユーザー、流通チャネル別-2025-2030年世界予測

グラニセトロン市場は2023年に70億1,000万米ドルと評価され、2024年には74億3,000万米ドルに達すると予測され、CAGR 6.58％で成長し、2030年には109億6,000万米ドルに達すると予測されています。

グラニセトロンは選択的5-HT3受容体拮抗薬であり、主に化学療法、放射線療法、術後環境による吐き気や嘔吐の予防に使用されます。グラニセトロンの必要性は、がん治療における一般的で衰弱させる副作用に対処する有効性からきており、それにより患者のQOLと治療コンプライアンスを向上させる。グラニセトロンの用途は、病院、腫瘍クリニック、術後回復センターなど多岐にわたり、包括的ながん治療レジメンの重要な構成要素となっています。経皮吸収パッチや徐放性注射剤などの新しい製剤が開発され、利便性と患者の服薬アドヒアランスの両方が向上するにつれて、最終用途の範囲は広がっています。

グラニセトロン市場は、がん罹患率の上昇、化学療法や放射線療法の普及拡大、ドラッグデリバリーシステムの進歩といった要因の影響を受けています。市場機会は、ヘルスケアインフラとがん治療へのアクセスが拡大している新興国におけるがん患者集団の成長から生じています。さらに、個別化医療と併用療法に焦点を当てた技術革新は、グラニセトロンの治療範囲を拡大し、ヘルスケア分野の企業に競争力を提供する態勢を整えています。

しかし、市場開拓にかかる高額な費用、ジェネリック医薬品競争につながる特許切れ、市場参入を遅らせる厳しい規制プロセスなどの課題に直面しています。また、副作用や相互作用による潜在的な限界もあり、慎重な患者管理と製剤の改良が必要となります。

事業の成長を促進するために、企業はバイオシミラーの開発、革新的なドラッグデリバリー方法、特定の患者のニーズや地域のヘルスケア需要に合わせた改良型製剤などの研究分野に注力すべきです。さらに、患者教育イニシアチブとデジタルヘルスプラットフォームに投資することで、市場への浸透とブランド・ロイヤルティを高めることができます。市場力学は、技術の進歩や制吐療法の改善に対する絶え間ない需要に牽引され、ダイナミックで競合的な性質を維持しています。北米と欧州の市場は先進的なヘルスケア施設によって大きなシェアを占めているが、アジア太平洋は医療費とがん罹患率の増加によって大きな成長の可能性を秘めています。

市場力学：急速に進化するグラニセトロン市場の主要市場インサイトを公開

グラニセトロン市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 新興国市場におけるヘルスケアインフラの開拓が市場の拡大を加速。
  • ヘルスケア支出の増加がグラニセトロンのような先進的制吐療法の採用を後押し
  • 製薬企業間の戦略的提携がグラニセトロンのイノベーションと市場浸透を促進
  • 制吐薬に対する有利な償還政策がグラニセトロンの普及を促進
• 市場抑制要因
  • 特許切れとグラニセトロン市場力学への影響の回避
• 市場機会
  • グラニセトロンを活用した革新的ながん治療薬とがん患者のケア改善
  • 胃腸障害や吐き気の治療におけるグラニセトロンの適応外使用の拡大
  • グラニセトロンの個別化医療への統合による患者の予後改善
• 市場の課題
  • グラニセトロンの安定供給に影響するサプライチェーンの脆弱性

ポーターの5つの力：グラニセトロン市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、グラニセトロン市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：グラニセトロン市場における外部からの影響の把握

外部マクロ環境要因は、グラニセトロン市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析グラニセトロン市場における競合情勢の把握

グラニセトロン市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスグラニセトロン市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、グラニセトロン市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨グラニセトロン市場における成功への道筋を描く

グラニセトロン市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 発展途上地域におけるヘルスケアインフラの拡大がグラニセトロン市場の拡大を加速
    • ヘルスケア費の増加は、グラニセトロンなどの高度な制吐治療の導入を後押ししています。
    • 製薬企業間の戦略的提携がグラニセトロンのイノベーションと市場浸透を推進
    • 制吐剤に対する有利な償還政策は、グラニセトロンの広範な使用を促進する
  • 抑制要因
    • 特許失効とグラニセトロン市場動向への影響を乗り越える
  • 機会
    • グラニセトロンを活用して革新的な腫瘍治療とがん患者ケアの改善を図る
    • 胃腸障害および吐き気の治療におけるグラニセトロンの適応外使用の拡大
    • より良い患者の転帰のために、グラニセトロンを個別化医療アプローチに統合する
  • 課題
    • グラニセトロンの一貫した可用性に影響を与えるサプライチェーンの脆弱性
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 グラニセトロン市場：製品タイプ別

• 注射液
• 経口液剤

第7章 グラニセトロン市場：用途別

• 化学療法による吐き気と嘔吐
• 術後の吐き気と嘔吐
• 放射線治療による吐き気と嘔吐

第8章 グラニセトロン市場：エンドユーザー別

• クリニック
  • 一般診療所
  • 腫瘍科クリニック
• ホームケア
• 病院
  • 私立病院
  • 公立病院

第9章 グラニセトロン市場：流通チャネル別

• 病院薬局
• オンライン薬局
• 小売薬局

第10章 南北アメリカのグラニセトロン市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のグラニセトロン市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのグラニセトロン市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 1. Akorn
• 2. Allergan
• 3. Amgen
• 4. Apotex
• 5. Aurobindo Pharma
• 6. Baxter International
• 7. Cipla
• 8. Dr. Reddy's Laboratories
• 9. Endo International
• 10. Fresenius Kabi
• 11. Glenmark Pharmaceuticals
• 12. Hoffmann-La Roche
• 13. Lupin Pharmaceuticals
• 14. Mylan
• 15. Natco Pharma
• 16. Pfizer
• 17. Sandoz
• 18. Sun Pharmaceutical
• 19. Teva Pharmaceuticals
• 20. Wockhardt

LIST OF FIGURES

• FIGURE 1. GRANISETRON MARKET RESEARCH PROCESS
• FIGURE 2. GRANISETRON MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GRANISETRON MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GRANISETRON MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GRANISETRON MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GRANISETRON MARKET DYNAMICS
• TABLE 7. GLOBAL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GRANISETRON MARKET SIZE, BY INJECTABLE SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GRANISETRON MARKET SIZE, BY ORAL SOLUTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GRANISETRON MARKET SIZE, BY CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GRANISETRON MARKET SIZE, BY POSTOPERATIVE NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GRANISETRON MARKET SIZE, BY RADIOTHERAPY-INDUCED NAUSEA AND VOMITING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GRANISETRON MARKET SIZE, BY GENERAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GRANISETRON MARKET SIZE, BY ONCOLOGY CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GRANISETRON MARKET SIZE, BY HOMECARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GRANISETRON MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GRANISETRON MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 25. GLOBAL GRANISETRON MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. GLOBAL GRANISETRON MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. GLOBAL GRANISETRON MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 39. ARGENTINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 40. ARGENTINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. BRAZIL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 44. BRAZIL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 45. BRAZIL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 46. BRAZIL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 47. CANADA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 48. CANADA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 49. CANADA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 50. CANADA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 51. CANADA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 52. CANADA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 53. MEXICO GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 54. MEXICO GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. MEXICO GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 56. MEXICO GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 57. MEXICO GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 58. MEXICO GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 59. UNITED STATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 60. UNITED STATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. UNITED STATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 62. UNITED STATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 63. UNITED STATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 64. UNITED STATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 65. UNITED STATES GRANISETRON MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 66. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 67. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 69. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 70. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 71. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 72. ASIA-PACIFIC GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 73. AUSTRALIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 74. AUSTRALIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 75. AUSTRALIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 76. AUSTRALIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 77. AUSTRALIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 78. AUSTRALIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 79. CHINA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 80. CHINA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. CHINA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 82. CHINA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 83. CHINA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 84. CHINA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 85. INDIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 86. INDIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 87. INDIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 88. INDIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 89. INDIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 90. INDIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 91. INDONESIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 92. INDONESIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. INDONESIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 94. INDONESIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 95. INDONESIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 96. INDONESIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 97. JAPAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 98. JAPAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 99. JAPAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 100. JAPAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 101. JAPAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 102. JAPAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 103. MALAYSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 104. MALAYSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. MALAYSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 106. MALAYSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 107. MALAYSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 108. MALAYSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 109. PHILIPPINES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 110. PHILIPPINES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 111. PHILIPPINES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 112. PHILIPPINES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 113. PHILIPPINES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 114. PHILIPPINES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 115. SINGAPORE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 116. SINGAPORE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. SINGAPORE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 118. SINGAPORE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 119. SINGAPORE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 120. SINGAPORE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 121. SOUTH KOREA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 122. SOUTH KOREA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 123. SOUTH KOREA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 124. SOUTH KOREA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 125. SOUTH KOREA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 126. SOUTH KOREA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 127. TAIWAN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 128. TAIWAN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. TAIWAN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 130. TAIWAN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 131. TAIWAN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 132. TAIWAN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 133. THAILAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 134. THAILAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 135. THAILAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 136. THAILAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 137. THAILAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 138. THAILAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 139. VIETNAM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 140. VIETNAM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. VIETNAM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 142. VIETNAM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 143. VIETNAM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 144. VIETNAM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 145. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 146. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 147. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 148. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 149. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 150. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 151. EUROPE, MIDDLE EAST & AFRICA GRANISETRON MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 152. DENMARK GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 153. DENMARK GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. DENMARK GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 155. DENMARK GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 156. DENMARK GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 157. DENMARK GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 158. EGYPT GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 159. EGYPT GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 160. EGYPT GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 161. EGYPT GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 162. EGYPT GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 163. EGYPT GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 164. FINLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 165. FINLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. FINLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 167. FINLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 168. FINLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 169. FINLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 170. FRANCE GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 171. FRANCE GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 172. FRANCE GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 173. FRANCE GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 174. FRANCE GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 175. FRANCE GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 176. GERMANY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 177. GERMANY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. GERMANY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 179. GERMANY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 180. GERMANY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 181. GERMANY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 182. ISRAEL GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 183. ISRAEL GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 184. ISRAEL GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 185. ISRAEL GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 186. ISRAEL GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 187. ISRAEL GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 188. ITALY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 189. ITALY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. ITALY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 191. ITALY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 192. ITALY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 193. ITALY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 194. NETHERLANDS GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 195. NETHERLANDS GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 196. NETHERLANDS GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 197. NETHERLANDS GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 198. NETHERLANDS GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 199. NETHERLANDS GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 200. NIGERIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 201. NIGERIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 202. NIGERIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 203. NIGERIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 204. NIGERIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 205. NIGERIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 206. NORWAY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 207. NORWAY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 208. NORWAY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 209. NORWAY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 210. NORWAY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 211. NORWAY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 212. POLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 213. POLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 214. POLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 215. POLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 216. POLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 217. POLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 218. QATAR GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 219. QATAR GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 220. QATAR GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 221. QATAR GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 222. QATAR GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 223. QATAR GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 224. RUSSIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 225. RUSSIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 226. RUSSIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 227. RUSSIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 228. RUSSIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 229. RUSSIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 230. SAUDI ARABIA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 231. SAUDI ARABIA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 232. SAUDI ARABIA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 233. SAUDI ARABIA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 234. SAUDI ARABIA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 235. SAUDI ARABIA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 236. SOUTH AFRICA GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 237. SOUTH AFRICA GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 238. SOUTH AFRICA GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 239. SOUTH AFRICA GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 240. SOUTH AFRICA GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 241. SOUTH AFRICA GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 242. SPAIN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 243. SPAIN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 244. SPAIN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 245. SPAIN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 246. SPAIN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 247. SPAIN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 248. SWEDEN GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 249. SWEDEN GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 250. SWEDEN GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 251. SWEDEN GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 252. SWEDEN GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 253. SWEDEN GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 254. SWITZERLAND GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 255. SWITZERLAND GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 256. SWITZERLAND GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 257. SWITZERLAND GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 258. SWITZERLAND GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 259. SWITZERLAND GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 260. TURKEY GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 261. TURKEY GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 262. TURKEY GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 263. TURKEY GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 264. TURKEY GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 265. TURKEY GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 266. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 267. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 268. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 269. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 270. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 271. UNITED ARAB EMIRATES GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 272. UNITED KINGDOM GRANISETRON MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
• TABLE 273. UNITED KINGDOM GRANISETRON MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 274. UNITED KINGDOM GRANISETRON MARKET SIZE, BY END USERS, 2018-2030 (USD MILLION)
• TABLE 275. UNITED KINGDOM GRANISETRON MARKET SIZE, BY CLINICS, 2018-2030 (USD MILLION)
• TABLE 276. UNITED KINGDOM GRANISETRON MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
• TABLE 277. UNITED KINGDOM GRANISETRON MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
• TABLE 278. GRANISETRON MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 279. GRANISETRON MARKET, FPNV POSITIONING MATRIX, 2023

The Granisetron Market was valued at USD 7.01 billion in 2023, expected to reach USD 7.43 billion in 2024, and is projected to grow at a CAGR of 6.58%, to USD 10.96 billion by 2030.

Granisetron is a selective 5-HT3 receptor antagonist primarily used to prevent nausea and vomiting caused by chemotherapy, radiation therapy, and post-operative environments. The necessity for Granisetron stems from its effectiveness in addressing a prevalent and debilitating side effect of cancer treatment, thereby improving patient quality of life and treatment compliance. Its applications span hospitals, oncology clinics, and post-surgical recovery centers, forming a crucial component of comprehensive cancer care regimens. The end-use scope broadens as newer formulations such as transdermal patches and extended-release injections are developed, offering both convenience and improved patient adherence.

The market for Granisetron is influenced by factors such as the rising prevalence of cancer, increasing adoption of chemotherapy and radiotherapy, and ongoing advancements in drug delivery systems. Market opportunities arise from the growth in cancer patient populations in emerging economies, where healthcare infrastructure and access to cancer care are expanding. Additionally, innovations focusing on personalized medicine and combination therapies are poised to expand the therapeutic scope of Granisetron, offering a competitive edge for businesses in the healthcare sector.

However, the market faces challenges, including the high cost of drug development, patent expirations leading to generic competition, and stringent regulatory processes that can delay market entry. Potential limitations also arise from adverse drug reactions and interactions, necessitating careful patient management and drug formulation enhancements.

To drive business growth, organizations should focus on research areas such as the development of biosimilars, innovative drug delivery methods, and enhanced formulations tailored to specific patient needs and regional healthcare demands. Additionally, investing in patient education initiatives and digital health platforms can enhance market penetration and brand loyalty. The nature of the Granisetron market remains dynamic and competitive, driven by technological advancements and a constant demand for improved antiemetic therapies. North American and European markets hold the lion's share due to advanced healthcare facilities, while Asia-Pacific offers substantial growth potential given its increasing healthcare expenditure and cancer incidence rates.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Granisetron Market

The Granisetron Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
  • Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
  • Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
  • Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
• Market Restraints
  • Navigating patent expirations and their impact on Granisetron market dynamics
• Market Opportunities
  • Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
  • Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
  • Integrating granisetron into personalized medicine approaches for better patient outcomes
• Market Challenges
  • Supply chain vulnerabilities impacting the consistent availability of Granisetron

Porter's Five Forces: A Strategic Tool for Navigating the Granisetron Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Granisetron Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Granisetron Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Granisetron Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Granisetron Market

A detailed market share analysis in the Granisetron Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Granisetron Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Granisetron Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Granisetron Market

A strategic analysis of the Granisetron Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Granisetron Market, highlighting leading vendors and their innovative profiles. These include Akorn, Allergan, Amgen, Apotex, Aurobindo Pharma, Baxter International, Cipla, Dr. Reddy's Laboratories, Endo International, Fresenius Kabi, Glenmark Pharmaceuticals, Hoffmann-La Roche, Lupin Pharmaceuticals, Mylan, Natco Pharma, Pfizer, Sandoz, Sun Pharmaceutical, Teva Pharmaceuticals, and Wockhardt.

Market Segmentation & Coverage

This research report categorizes the Granisetron Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Injectable Solution and Oral Solution.
• Based on Application, market is studied across Chemotherapy-Induced Nausea And Vomiting, Postoperative Nausea And Vomiting, and Radiotherapy-Induced Nausea And Vomiting.
• Based on End Users, market is studied across Clinics, Homecare, and Hospitals. The Clinics is further studied across General Clinics and Oncology Clinics. The Hospitals is further studied across Private Hospitals and Public Hospitals.
• Based on Distribution Channel, market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Expansion of healthcare infrastructure in developing regions accelerates granisetron market expansion
    • 5.1.1.2. Increase in healthcare expenditure supports the adoption of advanced antiemetic treatments such as granisetron
    • 5.1.1.3. Strategic collaborations between pharmaceutical companies drive innovation and market penetration of granisetron
    • 5.1.1.4. Favorable reimbursement policies for antiemetic medications encourage widespread use of granisetron
  • 5.1.2. Restraints
    • 5.1.2.1. Navigating patent expirations and their impact on Granisetron market dynamics
  • 5.1.3. Opportunities
    • 5.1.3.1. Leveraging granisetron for innovative oncology therapeutics and cancer patient care improvements
    • 5.1.3.2. Expanding off-label uses of granisetron in treating gastrointestinal disorders and nausea
    • 5.1.3.3. Integrating granisetron into personalized medicine approaches for better patient outcomes
  • 5.1.4. Challenges
    • 5.1.4.1. Supply chain vulnerabilities impacting the consistent availability of Granisetron
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Granisetron Market, by Product Type

• 6.1. Introduction
• 6.2. Injectable Solution
• 6.3. Oral Solution

7. Granisetron Market, by Application

• 7.1. Introduction
• 7.2. Chemotherapy-Induced Nausea And Vomiting
• 7.3. Postoperative Nausea And Vomiting
• 7.4. Radiotherapy-Induced Nausea And Vomiting

8. Granisetron Market, by End Users

• 8.1. Introduction
• 8.2. Clinics
  • 8.2.1. General Clinics
  • 8.2.2. Oncology Clinics
• 8.3. Homecare
• 8.4. Hospitals
  • 8.4.1. Private Hospitals
  • 8.4.2. Public Hospitals

9. Granisetron Market, by Distribution Channel

• 9.1. Introduction
• 9.2. Hospital Pharmacies
• 9.3. Online Pharmacies
• 9.4. Retail Pharmacies

10. Americas Granisetron Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Granisetron Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Granisetron Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Akorn
• 2. Allergan
• 3. Amgen
• 4. Apotex
• 5. Aurobindo Pharma
• 6. Baxter International
• 7. Cipla
• 8. Dr. Reddy's Laboratories
• 9. Endo International
• 10. Fresenius Kabi
• 11. Glenmark Pharmaceuticals
• 12. Hoffmann-La Roche
• 13. Lupin Pharmaceuticals
• 14. Mylan
• 15. Natco Pharma
• 16. Pfizer
• 17. Sandoz
• 18. Sun Pharmaceutical
• 19. Teva Pharmaceuticals
• 20. Wockhardt